Le Lézard
Classified in: Health
Subject: SVY

U.S. News Announces the 2020 Best Insurance Companies for Medicare


WASHINGTON, Oct. 15, 2019 /PRNewswire/ -- U.S. News & World Report, the global authority in healthcare rankings, today released the 2020 Best Insurance Companies for Medicare Advantage and Prescription Drug Plans. The new ratings are a resource for Medicare beneficiaries and their families searching for the best coverage options during the annual open-enrollment period, which began October 15 and runs through December 7, 2019.

The Best Insurance Companies for Medicare Advantage and Medicare Prescription Drug Plans highlights insurance companies that consistently offer highly rated health coverage to Medicare beneficiaries, who are typically age 65 or older.

"Medicare beneficiaries and their caregivers face an overwhelming number of options when identifying the best coverage for them and their families ? whether they are researching, choosing for the first time or switching plans," said Ben Harder, managing editor and chief of health analysis at U.S. News. "It is our mission at U.S. News to provide relevant and useful analysis to help consumers make a better informed choice of insurance that fits their specific needs."

Insurance companies were recognized if either their Medicare Advantage or their Part D prescription drug plans received an average rating of 4.5 stars or higher across all plans in a given state and whose plans were all rated as at least three out of five stars by the Centers for Medicare & Medicaid Services (CMS). Companies that consistently offer highly rated Medicare Advantage plans in multiple states include Aetna, Cigna, Kaiser Permanente, SelectHealth, Blue Cross Blue Shield, Senior Preferred, UnitedHealthcare, Martin's Point Generations and UPMC for Life. For Part D Prescription Drug plans, 12 states have one insurer that made the U.S. News list, with Blue Cross Blue Shield being the affiliate insurer in 11 of those 12 states.

U.S. News uses plan-ratings data from CMS to populate its comparison tool and identify the Best Insurance Companies for Medicare Advantage and Prescription Drug Plans. CMS rates individual plans on a scale of one to five stars. The U.S. News methodology analyzes insurers in a given state with plans rated three stars or higher by the CMS.

The Best Insurance Companies for Medicare Advantage and Prescription Drug Plans serve the broader U.S. News mission to provide trusted information and rankings that help Americans navigate complex health care decisions, including their choices of insurance plans, doctors, hospitals and nursing homes.

About U.S. News & World Report
U.S. News & World Report is the global leader in quality rankings that empower people to make better, more informed decisions about important issues affecting their lives. A digital news and information company focused on Education, Health, Money, Travel, Cars and Civic, USNews.com provides consumer advice, rankings and analysis to serve people making complex decisions throughout all stages of life. More than 40 million people visit USNews.com each month for research and guidance. Founded in 1933, U.S. News is headquartered in Washington, D.C.

SOURCE U.S. News & World Report


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: